Estimating the cost-effectiveness of flutamide in metastatic cancer.
Hillner
B E
BE
Department of Internal Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0170, USA.
D000368:Aged; D000726:Androgen Antagonists / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D005485:Flutamide / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D009919:Orchiectomy; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000401:mortality
D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D005485:Flutamide